PortfoliosLab logoPortfoliosLab logo
WELS.DE vs. PPH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WELS.DE vs. PPH - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Amundi S&P Global Health Care ESG UCITS ETF EUR Acc (WELS.DE) and VanEck Vectors Pharmaceutical ETF (PPH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

WELS.DE is traded in EUR, while PPH is traded in USD. To make them comparable, the PPH values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, WELS.DE achieves a -3.35% return, which is significantly lower than PPH's 3.80% return.


WELS.DE

1D
2.97%
1M
4.14%
YTD
-3.35%
6M
-2.82%
1Y
6.93%
3Y*
2.22%
5Y*
10Y*

PPH

1D
3.27%
1M
3.04%
YTD
3.80%
6M
6.64%
1Y
19.39%
3Y*
10.18%
5Y*
10.98%
10Y*
7.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

WELS.DE vs. PPH - Yearly Performance Comparison


2026 (YTD)2025202420232022
WELS.DE
Amundi S&P Global Health Care ESG UCITS ETF EUR Acc
-3.35%1.05%7.20%2.33%4.02%
PPH
VanEck Vectors Pharmaceutical ETF
3.80%7.52%15.18%3.74%3.92%

Correlation

The correlation between WELS.DE and PPH is 0.72, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.72

Correlation (3Y)
Calculated over the trailing 3-year period

0.61

Correlation (All Time)
Calculated using the full available price history since Oct 12, 2022

0.60

The correlation between WELS.DE and PPH shifts across timeframes, from 0.60 (all time) to 0.72 (1 year), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WELS.DE vs. PPH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WELS.DE
WELS.DE Risk / Return Rank: 1616
Overall Rank
WELS.DE Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
WELS.DE Sortino Ratio Rank: 1717
Sortino Ratio Rank
WELS.DE Omega Ratio Rank: 1616
Omega Ratio Rank
WELS.DE Calmar Ratio Rank: 1616
Calmar Ratio Rank
WELS.DE Martin Ratio Rank: 1515
Martin Ratio Rank

PPH
PPH Risk / Return Rank: 3636
Overall Rank
PPH Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
PPH Sortino Ratio Rank: 3838
Sortino Ratio Rank
PPH Omega Ratio Rank: 3535
Omega Ratio Rank
PPH Calmar Ratio Rank: 4141
Calmar Ratio Rank
PPH Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WELS.DE vs. PPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amundi S&P Global Health Care ESG UCITS ETF EUR Acc (WELS.DE) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WELS.DEPPHDifference
Sharpe ratioReturn per unit of total volatility

-0.67

Sortino ratioReturn per unit of downside risk

-0.98

Omega ratioGain probability vs. loss probability

1.09

1.21

-0.12

Calmar ratioReturn relative to maximum drawdown

0.56

1.94

-1.39

Martin ratioReturn relative to average drawdown

1.30

4.48

-3.19

WELS.DE vs. PPH - Sharpe Ratio Comparison

The current WELS.DE Sharpe Ratio is 0.47, which is lower than the PPH Sharpe Ratio of 1.14. The chart below compares the historical Sharpe Ratios of WELS.DE and PPH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


WELS.DEPPHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.47

1.14

-0.67

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.73

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.43

Sharpe Ratio (All Time)

Calculated using the full available price history

0.22

0.52

-0.30

Drawdowns

WELS.DE vs. PPH - Drawdown Comparison

The maximum WELS.DE drawdown since its inception was -23.13%, smaller than the maximum PPH drawdown of -31.54%. Use the drawdown chart below to compare losses from any high point for WELS.DE and PPH.


Loading charts...

Drawdown Indicators


WELS.DEPPHDifference

Max Drawdown

Largest peak-to-trough decline

-23.13%

-31.54%

+8.41%

Max Drawdown (1Y)

Largest decline over 1 year

-12.35%

-10.02%

-2.33%

Max Drawdown (3Y)

Largest decline over 3 years

-23.13%

-20.54%

-2.59%

Max Drawdown (5Y)

Largest decline over 5 years

-20.54%

Max Drawdown (10Y)

Largest decline over 10 years

-28.74%

Current Drawdown

Current decline from peak

-12.08%

-3.51%

-8.57%

Average Drawdown

Average peak-to-trough decline

-7.30%

-9.92%

+2.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.34%

4.33%

+1.01%

Volatility

WELS.DE vs. PPH - Volatility Comparison

The current volatility for Amundi S&P Global Health Care ESG UCITS ETF EUR Acc (WELS.DE) is 5.27%, while VanEck Vectors Pharmaceutical ETF (PPH) has a volatility of 6.05%. This indicates that WELS.DE experiences smaller price fluctuations and is considered to be less risky than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WELS.DEPPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.27%

6.05%

-0.78%

Volatility (6M)

Calculated over the trailing 6-month period

10.22%

11.95%

-1.73%

Volatility (1Y)

Calculated over the trailing 1-year period

14.60%

17.07%

-2.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

13.59%

15.19%

-1.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

13.59%

17.45%

-3.86%

WELS.DE vs. PPH - Expense Ratio Comparison

WELS.DE has a 0.18% expense ratio, which is lower than PPH's 0.36% expense ratio.


Dividends

WELS.DE vs. PPH - Dividend Comparison

WELS.DE has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 2.05%.


PositionTTM20252024202320222021202020192018201720162015
PPH
VanEck Vectors Pharmaceutical ETF
2.05%1.78%1.98%2.09%1.55%1.62%1.66%1.77%1.97%1.92%2.43%1.93%
WELS.DE
Amundi S&P Global Health Care ESG UCITS ETF EUR Acc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


WELS.DE and PPH have a correlation of 0.72, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, WELS.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.

WELS.DE is cheaper with a 0.18% expense ratio, compared with 0.36% for PPH.

WELS.DE tracks S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care, while PPH tracks MVIS US Listed Pharmaceutical 25 Index. They also come from different issuers: Amundi and VanEck. Their fees differ too: 0.18% for WELS.DE and 0.36% for PPH.

Portfolio Optimizer

Find the right allocation for WELS.DE and PPH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer